protein kinase C epsilon | Eta subfamily | IUPHAR Guide to IMMUNOPHARMACOLOGY

Top ▲

protein kinase C epsilon

Target id: 1486

Nomenclature: protein kinase C epsilon

Abbreviated Name: PKCε

Family: Eta subfamily

Annotation status:  image of an orange circle Annotated and awaiting review. Please contact us if you can help with reviewing.  » Email us

   GtoImmuPdb view: ON :     protein kinase C epsilon has curated data in GtoImmuPdb

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 737 2p21 PRKCE protein kinase C epsilon
Mouse - 737 17 Prkce protein kinase C, epsilon
Rat - 737 6q12 Prkce protein kinase C, epsilon
Previous and Unofficial Names
nPKC-epsilon | PKCepsilon | protein kinase C, epsilon | protein kinase C
Database Links
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Enzyme
RefSeq Nucleotide
RefSeq Protein
Selected 3D Structures
Image of receptor 3D structure from RCSB PDB
Resolution:  1.7Å
Species:  Human
References:  9
Enzyme Reaction
EC Number:

Download all structure-activity data for this target as a CSV file

Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
ingenol mebutate Hs Activation 9.8 pKi 8
pKi 9.8 (Ki 1.71x10-10 M) [8]
RasGRP activator 1 Hs Binding 7.7 pKi 7
pKi 7.7 (Ki 2.11x10-8 M) [7]
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
sotrastaurin Hs Inhibition 8.2 pIC50 11
pIC50 8.2 (IC50 6.2x10-9 M) [11]
balanol Hs Inhibition 7.7 pIC50 4
pIC50 7.7 (IC50 2x10-8 M) [4]
chelerythrine Hs Inhibition 7.6 pIC50 5
pIC50 7.6 (IC50 2.4x10-8 M) [5]
Ro-32-0432 Mm Inhibition 7.0 pIC50 2,12
pIC50 7.0 (IC50 1.08x10-7 M) [2,12]
Y27632 Hs Inhibition 6.5 pIC50 14
pIC50 6.5 (IC50 3.35x10-7 M) [14]
7-hydroxystaurosporine Hs Inhibition 6.3 pIC50 10
pIC50 6.3 (IC50 5.3x10-7 M) [10]
View species-specific inhibitor tables
DiscoveRx KINOMEscan® screen
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
Reference: 3,13

Key to terms and symbols Click column headers to sort
Target used in screen: PRKCE
Ligand Sp. Type Action Affinity Units
staurosporine Hs Inhibitor Inhibition 9.6 pKd
GSK690693 Hs Inhibitor Inhibition 8.3 pKd
enzastaurin Hs Inhibitor Inhibition 8.1 pKd
PP-242 Hs Inhibitor Inhibition 8.1 pKd
ruboxistaurin Hs Inhibitor Inhibition 8.0 pKd
A-674563 Hs Inhibitor Inhibition 8.0 pKd
lestaurtinib Hs Inhibitor Inhibition 6.8 pKd
alvocidib Hs Inhibitor Inhibition 6.4 pKd
ruxolitinib Hs Inhibitor Inhibition 6.3 pKd
midostaurin Hs Inhibitor Inhibition 6.3 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service.

A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform.

Reference: 1,6

Key to terms and symbols Click column headers to sort
Target used in screen: PKCε/PKCepsilon
Ligand Sp. Type Action % Activity remaining at 0.5µM % Activity remaining at 1µM % Activity remaining at 10µM
GF109203X Hs Inhibitor Inhibition 0.5 10.0 1.0
staurosporine Hs Inhibitor Inhibition 0.8 1.0 -0.5
Ro-32-0432 Hs Inhibitor Inhibition 2.7
K-252a Hs Inhibitor Inhibition 10.6 51.0 10.0
midostaurin Hs Inhibitor Inhibition 10.7 42.0 14.0
Cdk1/2 inhibitor III Hs Inhibitor Inhibition 11.5 30.0 8.0
PKCbeta inhibitor Hs Inhibitor Inhibition 12.8 21.0 3.0
Gö 6983 Hs Inhibitor Inhibition 14.6 3.0 0.0
PKR inhibitor Hs Inhibitor Inhibition 19.5 27.0 9.0
bisindolylmaleimide IV Hs Inhibitor Inhibition 24.0 63.0 21.0
Displaying the top 10 most potent ligands  View all ligands in screen »


Show »

1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1039-45. [PMID:22037377]

2. Birchall AM, Bishop J, Bradshaw D, Cline A, Coffey J, Elliott LH, Gibson VM, Greenham A, Hallam TJ, Harris W et al.. (1994) Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. J. Pharmacol. Exp. Ther., 268 (2): 922-9. [PMID:8114006]

3. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol., 29 (11): 1046-51. [PMID:22037378]

4. Defauw JM, Murphy MM, Jagdmann Jr GE, Hu H, Lampe JW, Hollinshead SP, Mitchell TJ, Crane HM, Heerding JM, Mendoza JS et al.. (1996) Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A. J. Med. Chem., 39 (26): 5215-27. [PMID:8978850]

5. Fedorov O, Marsden B, Pogacic V, Rellos P, Müller S, Bullock AN, Schwaller J, Sundström M, Knapp S. (2007) A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc. Natl. Acad. Sci. U.S.A., 104 (51): 20523-8. [PMID:18077363]

6. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013) A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. Biochem. J., 451 (2): 313-28. [PMID:23398362]

7. Garcia LC, Donadío LG, Mann E, Kolusheva S, Kedei N, Lewin NE, Hill CS, Kelsey JS, Yang J, Esch TE et al.. (2014) Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP. Bioorg. Med. Chem., 22 (12): 3123-40. [PMID:24794745]

8. Kedei N, Lundberg DJ, Toth A, Welburn P, Garfield SH, Blumberg PM. (2004) Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res., 64 (9): 3243-55. [PMID:15126366]

9. Ochoa WF, Garcia-Garcia J, Fita I, Corbalan-Garcia S, Verdaguer N, Gomez-Fernandez JC. (2001) Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains. J. Mol. Biol., 311 (4): 837-49. [PMID:11518534]

10. Seynaeve CM, Kazanietz MG, Blumberg PM, Sausville EA, Worland PJ. (1994) Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol. Pharmacol., 45 (6): 1207-14. [PMID:8022414]

11. Wagner J, von Matt P, Sedrani R, Albert R, Cooke N, Ehrhardt C, Geiser M, Rummel G, Stark W, Strauss A et al.. (2009) Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes. J. Med. Chem., 52 (20): 6193-6. [PMID:19827831]

12. Wilkinson SE, Parker PJ, Nixon JS. (1993) Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J., 294 ( Pt 2): 335-7. [PMID:8373348]

13. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem. Biol., 17 (11): 1241-9. [PMID:21095574]

14. Wu F, Büttner FH, Chen R, Hickey E, Jakes S, Kaplita P, Kashem MA, Kerr S, Kugler S, Paw Z et al.. (2010) Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account. Bioorg. Med. Chem. Lett., 20 (11): 3235-9. [PMID:20462760]

How to cite this page

Eta subfamily: protein kinase C epsilon. Last modified on 28/08/2018. Accessed on 18/01/2019. IUPHAR/BPS Guide to PHARMACOLOGY,